Nalmefene Hydrochloride
Who holds supplier records for Nalmefene Hydrochloride? 4 organisations hold a current record for Nalmefene Hydrochloride: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: United States (2), India (1) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Nalmefene Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/nalmefene-hydrochloride
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nalmefene Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- PURISYS LLCUnited StatesActive DMF 39767 · latest filing Aug 2024
- RUSAN PHARMA LTDIndia Company GMP cert on recordActive DMF 34367 · latest filing Dec 2019
- Sichuan Qingmu Pharmaceutical Co., Ltd.ChinaActive DMF 36751 · latest filing Mar 2022
- SPECGX LLCUnited StatesActive DMF 15663 · latest filing Oct 2001
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Nalmefene Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- TASMANIAN ALKALOIDS PROPRIETARY LTDInactive DMF 8507 · filed Mar 1990
- United States · Inactive DMF 5642 · filed Dec 1984
- France · Inactive DMF 5484 · filed Aug 1984
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Nalmefene Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201152).
Chemical identity
- IUPAC name
- (4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;hydrochloride
- Canonical SMILES
- C=C1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6)O.Cl
- InChIKey
- GYWMRGWFQPSQLK-OPHZJPRHSA-N
- Synonyms
- JF-1 HYDROCHLORIDE, Nalmefene hcl, Nalmefene hydrochloride, Opvee, Revex, Zurnai, Zurnai (autoinjector), RefChem:57226, nalmefene hydrochloride injection, Nalmefenehydrochloride, Revex (TN), Nalmefene?hydrochloride
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Opioid Antagonist
- Mechanism of action
- Opioid Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nalmefene Hydrochloride?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Nalmefene Hydrochloride: PURISYS LLC (United States), RUSAN PHARMA LTD (India), Sichuan Qingmu Pharmaceutical Co., Ltd. (China) and SPECGX LLC (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nalmefene Hydrochloride Drug Master Files are active?
PURISYS LLC (DMF 39767), RUSAN PHARMA LTD (DMF 34367), Sichuan Qingmu Pharmaceutical Co., Ltd. (DMF 36751) and SPECGX LLC (DMF 15663). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Nalmefene Hydrochloride records mean?
3 organisations have only inactive Type II DMFs for Nalmefene Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Nalmefene Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nalmefene Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.